bromocriptine mesylate /brō′mōkrip″tēn/ , a dopamine receptor agonist. ▪ INDICATIONS: It is prescribed for the treatment of amenorrhea and galactorrhea associated with hyperprolactinemia, female infertility, Parkinson’s disease, and type 2 diabetes. ▪ CONTRAINDICATIONS: Sensitivity to any ergot alkaloid prohibits its use. The drug was disqualified for use in suppressing postpartum lactation by the FDA in 1994 because of a previously unrecognized increase in intracranial hemorrhages. ▪ ADVERSE EFFECTS: Among the more severe adverse reactions are palpitations, hypotension, bradycardia, hallucinations, syncope, nausea, ataxia, dyspnea, dysphagia, and confusion.
